Minimal change nephrotic syndrome - A complex genetic disorder

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 3, 2000, Pages 351-356

  Gong, W K ^b   Chng, W ^b   Yap, Hui Kim ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NONE

Author keywords

Angiotensin converting enzyme gene; Cytokines; Flt 1; Gene polymorphism; Human leukocyte antigen

Indexed keywords

CYTOKINE;

GENE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; HUMAN; LIPOID NEPHROSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

CYTOKINES; GENE EXPRESSION; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEPHROSIS, LIPOID; RENIN-ANGIOTENSIN SYSTEM;

EID: 0034184585     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Schnaper H W. Primary nephrotic syndrome of childhood. Curr Opin Pediatr 1996; 8:141-7.
2. Salcedo J R, Chan J CM. Nephrotic syndrome. In: Burg F D, Ingelfinger J R, Wald E R, editors. Gellis and Kagan's Current Pediatric Therapy. Orlando: Saunders, 1993:357-9.
3. Shalhoub R J. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2:556-9.
4. Norio R. The nephritic syndrome and heredity. Hum Hered 1969; 19: 113-20.
5. Roy S, Pitcock J A. Idiopathic nephrosis in identical twins. Am J Dis Child 1971; 121:428-30.
6. White R H R. The familial nephrotic syndrome. Int Arch Eur Surg Clin Nephrol 1973; 1:215-9.
7. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98:561-4.
8. Thomson P D, Barratt T M, Stokes C R, Turner M W, Soothil J F. HLA antigens and atopic features in steroid-responsive nephritic syndrome of childhood. Lancet 1976; II:765-8.
9. O'Reagan E, O'Callaghan V, Dundon S. HLA antigens and steroid responsive nephritic syndrome of childhood. Tissue Antigens 1980; 16:147-51.
10. Noss G, Bachmann H J, Olbing H. Association of minimal change nephrotic syndrome (MCNS) with HLA-B8 and B13. Clin Nephrol 1981; 15:172-4.
11. Trompeter R S, Barratt T M, Kay R, Turner M W, Soothill J F. HLA, atopy, and cyclophosphamide in steroid responsive childhood nephritic syndrome. Kidney Int 1980; 17:113-7.
12. Boissou F, Cambon-Thomsen A, Abbal M, Calot M, Kuhlein E, Barthe P, et al. HLA typing and immunological studies in steroid sensitive (SS) and steroid resistant (SR) idiopathic nephrotic syndrome (INS) in children [abstract]. Helvet Fed Acta 1980; 41:144.
13. Kobayashi Y, Chen X M, Hiki Y, Fujii K, Kashiwagi N. Association of HLA-DRw8 and DQw3 with minimal change nephrotic syndrome in Japanese adults. Kidney Int 1985; 28:193-7.
14. Mouzon-Cambon A, Bouissou F, Dutau G, Barthe P, Parra M T, Sevin A, et al. HLA-DR7 in children with idiopathic nephrotic syndrome. Correlation with atopy. Tissue Antigens 1981; 17:518-24.
15. Clark A G B, Vaughan R W, Stephens H A F, Chantler C, Williams D G, Welsh K I. Genes encoding the β-chains of HLA-DR7 and HLADQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci 1990; 78:391-7.
16. Zaki M, Daoud A S, Saleh Q A A, Najedi A K A, White A G. HLA antigens in Arab children with steroid-responsive nephrotic syndrome. Pediatr Nephrol 1994; 8:74-5.
17. Zhou G P, Guo Y Q, Ji Y H, Zhang G L. Major histocompatibility complex class II antigens in steroid-sensitive nephrotic syndrome in Chinese children. Pediatr Nephrol 1994; 8:140-1.
18. Konrad M, Mytilineos J, Bouissou F, Scherer S, Gulli M P, Meissner I, et al. HLA class II associations with idiopathic nephrotic syndrome in children. Tissue Antigens 1994; 43:275-80.
19. Bouissou F, Meissner I, Konrad M, Sommer E, Mytilineos J, Ohayon E, et al. Clinical implications from studies of HLA antigens in idiopathic nephrotic syndrome in children. Clin Nephrol 1995; 44:279-83.
20. Konrad M, Mytilineos J, Ruder H, Opelz G, Schärer K. HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 1997; 11:16-9.
21. Lagueruela C C, Buettner T L, Cole B R, Kissane J M, Robson A M. HLA extended haplotypes in steroid-sensitive nephrotic syndrome of childhood. Kidney Int 1990; 38:145-50.
22. Cheung W, Ren E C, Chan S H, Gong W K, Murugasu B, Yap H K. Increased HLA-A11 in Chinese children with steroid-responsive nephrotic syndrome [abstract]. J Am Soc Nephrol 1999: 10:509A.
23. Soubrier F, Wei L, Hurbert C, Clauser E, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme: II. Structurefunction, gene polymorphism and clinical implications. J Hypertens 1993; 11:599-604.
24. Jardine A G. Angiotensin II and glomerulonephritis. J Hypertens 1995; 13:487-93.
25. Gloy J, Henger A, Fischer K G, Nitschke R, Bleich M, Mundel P, et al. Angiotensin II modulated cellular function of podocytes. Kidney Int 1998; 54:S 168-70.
26. Ibarra-Rubio M E, Cruz C, Tapia E, Pena J C, Pedraza-Chaverri J. Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats. Clin Exp Pharmacol Physiol 1990; 6: 391-9.
27. Arevalo A E, Ibarra-Rubio M E, Cruz C, Pena J C, Pedraza-Chaverri J. Angiotensin I-converting enzyme activity in puromycin amino nucleoside-nephrotic syndrome. Clin Chim Acta 1990; 191:175-84.
28. Kurkus J, Thysell H. Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders. Scand J Urol Nephrol 1990; 24:63-8.
29. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene T T, Hailab M, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43:384-8.
30. Miller J A, Scholey J W, Thai K, Pei Y P C. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetics. Kidney Int 1997; 51:119-24.
31. Hunley T E, Julian B A, Philip J A, Summar M L, Yoshida H, Horn R G, et al. Angiotensin converting enzyme gene polymorphism: potential silent motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49:571-7.
32. Lee D Y, Kim W, Kang S K, Koh G Y, Park S K. Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmentai glomerulosclerosis. Nephron 1997; 77:471-3.
33. Frishberg Y, Becker-Cohen R, Halle D, Feigin E, Eisenstein B, Halevy R, et al. Genetic polymorphisms of the renin-angiotensin system and the outcome of focal segmental glomerulosclerosis in children. Kidney Int 1998; 54:1843-9.
34. Yap H K, Cheung W, Loh W L, Murugasu B, Tay AHN. Polymorphisms of angiotensin-converting enzyme (ACE) gene inchildren with idiopathic nephrotic syndrome [abstract]. J Am Soc Nephrol 1997; 8:546A.
35. Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawaihi H, et al. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999; 55:877-89.
36. Pagtalunan M E, Rasch R, Rennke H G, Meyer T W. Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol 1995; 268:F82-8.
37. Caulfield M, Lavendor P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330:1629-33.
38. Jeunemaitre X, Soubrier F, Kotelevtsev Y V, Lifton R P, Williams C S, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-80.
39. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, et al. Effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphisms on risk of myocardium function. Lancet 1994; 334:910-3.
40. Hibi M, Hirano T. Signal transduction through cytokine receptors. Int Rev Immunol 1998; 17:75-102.
41. Onishi M, Nosaka T, Kitamura T. Cytokine receptors: structures and signal transduction. Int Rev Immunol 1998; 16:617-34.
42. Rubinstein M, Dinarello C A, Oppenheim J J, Hertzog P. Recent advances in cytokines, cytokine receptors and signal transduction. Cytokine Growth Factor Rev 1998; 9:175-81.
43. Carpenter L R, Yancopoulus G D, Stahl N. General mechanisms of cytokine receptor signaling. Adv Protein Chem 1998; 52:109-40.
44. Ihle J N, Thierfelder W, Teglund S, Stravapodis D, Wang D, Feng J, et al. Signalling by the cytokine receptor superfamily. Ann NY Acad Sci 1998; 865:1-9.
45. Mosmann T R, Cherwinski H, Bond M W, Giedli M A, Coffman R L. Two types of murine helper T-cell clone - definition according to profiles of lymphocyte activities and secreted proteins. J Immunol 1986; 136:2348-57.
46. Cerwenka A, Carter L L, Reome J B, Swain S L, Dutton R W. In vivo persistence of CDS polarized T cell subsets producing type 1 or type 2 cytokines. Immunol 1998; 161:97-105.
47. Bidwell J L, Wood NAP, Morse H R, Olomolaiye O O, Laundy G J. Human cytokine gene nucleotide sequence alignments. Eur J Immunogenet 1998; 25:83-265.
48. Bidwell J L, Wood NAP, Morse H R, Olomolaiye O O, Keen L J, Laundy G J. Human cytokine gene nucleotide sequence alignments. Eur J Immunogenet 1999; 26 (Suppl 1): 135-223.
49. Bidwell J L. Nuclear matrix proteins and osteoblasi gene expression. J Bone Miner Res 1998; 13:155-67.
50. Schnaper H W. The immune system in minimal change nephrotic syndrome. Pediatr Nephrol 1989; 3:101-10.
51. Matsumoto K. Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis. Clin Nephrol 1989; 31:292-6.
52. Saxena S, Mittal A, Andal A. Pattern of interleukins in minimal-change nephrotic syndrome of childhood. Nephron 1993; 65:56-61.
53. Bustos C, González E, Muley R, Alonso J L, Egido J. Increase of tumor necrosis factor synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994; 24:799-805.
54. Neuhaus T J, Wadhwa M, Callard R, Barratt T M. Increased IL-2, IL-4, and interferon-gamma (IFNγ) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 1995; 100:475-9.
55. Liu X, Yang J, Wang S. Interleukin-1 beta, interleukin-1 receptor antagonist mRNA expression of peripheral blood mononuclear cells (PBMC) in idiopathic nephrotic syndrome (INS) detected by biotinlabelled probe in situ hybridization. Chung Hua I Hsueh Tsa Chih 1995; 75:152-4.
56. Garin E H, Blanchard D K, Matsushima K, Djeu J Y. IL-8 production by peripheral blood mononuclear cells in nephrotic syndrome. Kidney Int 1994; 45:1311-7.
57. Yap H K, Cheung W, Murugasu B, Jordan S C. Downregulation of monokine genes in children with relapses of steroid-responsive nephrotic syndrome [abstract], Pediatr Nephrol 1998; 12:C96.
58. Matsumoto K, Kanmatsuse K. Increased IL-12 release by monocytes in nephrotic patients. Clin Exp Immunol 1999; 117:361-7.
59. Matsumoto K, Kanmatsuse K. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome. Clin Nephrol 1999; 52:10-8.
60. Hulton S A, Shah V, Byrne M R, Morgan G, Barratt T M, Dillon M J. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 1994; 8:135-9.
61. Yap H K, Cheung W, Murugasu B, Sim S K, Seah C C, Jordan S C. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999; 10:529-37.
62. Matsumoto K. Decreased release of IL-10 by monocytes from patients with lipoid nephrosis. Clin Exp Immunol 1995; 102:603-7.
63. Cho B S, Yoon S R, Jang J Y, Pyun K H, Lee C E. Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 1999; 13:199-204.
64. Meadow S R, Sarsfield J K. Steroid-responsive nephrotic syndrome and allergy: clinical studies. Arch Dis Child 1981; 56:509-16.
65. Yap H K, Yip W C L, Lee B W, Teo J, Aw S E, Tay J S H. The incidence of atopy in steroid-responsive nephrotic syndrome: clinical and immunological parameters. Ann Allergy 1983; 51:590-4.
66. Lin C Y, Lee B H, Lin C C, Chen W P. A study of the relationship between childhood nephrotic syndrome and allergic diseases. Chest 1990; 97:1408-11.
67. Meadow S R, Sarsfield J K, Scott D G, Rajah S M. Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child 1981; 56:517-24.
68. Wardle E N. Minimal change nephrosis and allergy. Nephron 1996; 74:422-3.
69. Del Prete G. Human Th1 and Th2 lymphocytes: Their role in the pathophysiology of atopy. Allergy 1992; 47:450-5.
70. Casolaro V, Georas S N, Song Z, Ono S J. Biology and genetics of atopic disease. Curr Opin Immunol 1996; 8:796-803.
71. Hershey G K K, Friedrich M F, Esswein L A, Thomas M L, Chatila T A. The association of atopy with a gain of function mutation in the subunit of the interleukin-4 receptor. N Engl J Med 1997; 337:1720-5.
72. Mitsuyasu H, Izuhara K, Mao X, Gao P, Arinobu Y, Enomoto T. Ile5OVal variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19:119-20.
73. Rosenwasser L J, Klemm D J, Dresback J K, Inamura H, Mascali J J. Klinnert M. Prometer polymorphism in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25 (Suppl 2):74-8.
74. Song Z, Casolaro V, Chen R, Georas S, Monos D, Ono S J. Polymorphic nucleotides within the human IL-4 prometer that mediate overexpression of the gene. J Immunol 1996; 156:424-9.
75. Van der Pouw Kraan T C, Van Veen A, Boeije L C M, Van Tuyl S A P, De Groot E R, Stapel S O, et al. An IL-13 prometer polymorphism associated with increased risk of allergic asthma. Genes Immunity 1999; 1:61-5.
76. Parry R G, Gillespie K M, Parnham A, Clark A G, Mathieson P W. Interleukin-4 and interleukin-4 receptor polymorphism in minimal change nephropathy. Clin Sci 1999; 96:665-8.
77. Sobel A, Heslan J M, Branellac A, Lagrue G. Vascular permeability factor produced by lymphocytes of patients with nephrotic syndrome. Adv Nephrol 1981; 10:315-32.
78. Brown L F, Detmar M, Claffey K, Nagy J A, Feng D, Dvorak A M, et al. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 1997; 79:233-69.
79. Brown L F, Berse B, Tognazzi K, Manseau E J Van de Water L, Senger D R, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992; 42:1457-61.
80. Grone H J, Simon M, Grone E F. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 1995; 177:259-67.
81. Simon M, Grone H J, Johren O, Kullmer J, Plate -K H, Risau W, et al. Expression of vascular endothelial growth factor and its receptor in human renal ontogenesis and in adult kidney. Am J Physiol 1995; 268:F240-50.
82. Esser S, Wolburg K, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestration in vitro. J Cell Biol 1998; 140:947-59.
83. Kendall R L, Thomas K A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 1993; 90:10705-9.
84. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushimime H, et al. Nucleotide sequence and expression of a novel human receptortype tyrosine kinase gene (flt) closely related to fms family. Oncogene 1990; 5:519-24.
85. Polymeropoulos M H, Rath D S, Xiao H, Merril C R. Dinucleotide repeat polymorphism at the human fms-related tyrosine kinase gene. Nucleic Acids Res 1991; 19:2803.
86. Han H, Fujiwara T, Shin S, Nakamura Y. Dinucleotide repeat polymorphism in the 3' non-coding region of the FLT 1 gene. Hum Mol Genet 1993; 2:2204.
87. Wang E, Ma W J, Aghajanian C, Spriggs D R. Post-transcriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine rich elements in the 3′ untranslated region of tumour necrosis factor-α messenger RNA. Cancer Res 1997; 57:5426-33.
88. Bailey E, Bottomley M J, Westwell S, Pringle J H, Furness P N, Feehally J, et al. Vascular endothelial growth factor mRNA expression in minimal change, membranous and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol 1999; 52:735-8.
89. Parry R G, Gillespie K M, Clark A G, Mathieson P W. Dinucleotide repeat polymorphism within Flt-1 gene in minimal change nephropathy. Eur J Immunogenet 1999; 26:321-3.